Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A new lead in treating chronic social defeat stress

Published on: 24/05/2017 Reading time: 1 min
Une personne en dépression
Retour à la recherche

24Chronic social defeat stress is a cause in many cases of depression. In humans, chronic social stress is built over time based on our past social interaction, with numerous consequences on both a psychological and neurological level.

Beyond depression, many patients display cognitive disorders including memory and attention loss, and complicated decision-making. Current therapy is focused on treating depression, yet its impact on cognitive deficiency remains unclear.

Institut du Cerveau - ICM researchers focused on the behavioral and molecular impact of chronic social defeat stress in an experimental model summarizing similar symptoms to those observed in humans. They also studied the effect of a molecule named agomelatine that has demonstrated antidepressant and anxiolytic effects.

In addition to behavioral modifications and memory disorders observed in animals, researchers highlighted a decrease in the expression of certain genes of the hippocampus, an area of the brain that plays a crucial role in memory and known to be directly affected in social stress. Results showed that agomelatine has an effect on cognitive disorders and gene expression in the hippocampus.

This data suggests that agomelatine may be of particular interest in treating cognitive disorders associated with depression. Complementary studies will focus on studying the molecule’s mechanisms.

Sources

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
https://www.nature.com/articles/srep45907
Martin V, Allaïli N, Euvrard M, Marday T, Riffaud A, Franc B, Mocaër E, Gabriel C, Fossati P, Lehericy S, Lanfumey L. Sci Rep. 2017 Apr 4;8:45907

Our news on the subject

La bibliothèque de Babel
Mental Time Travel: A New Case of Autobiographical Hypermnesia
Remembering past events in minute detail, revisiting them methodically, and reliving past emotions—this is the peculiarity of people with an exceptional memory of their own lives, known as autobiographical hypermnesia, or hyperthymesia. This...
08.28.2025 Research, science & health
Crédit : Ana Yael.
An International Database to Better Understand Dreams
In an article published in Nature Communications, researchers from 37 scientific institutions—including Paris Brain Institute—unveil the DREAM database: an ambitious project designed to centralize, share, and standardize data from research on sleep...
08.14.2025 Research, science & health
Le cortex moteur
Origin of Lance-Adams Syndrome Finally Elucidated
First described 60 years ago, chronic myoclonus following cerebral anoxia is now known as Lance-Adams syndrome. This is a severe disorder whose mechanisms were, until now, poorly understood. Geoffroy Vellieux, Vincent Navarro, and their colleagues at...
06.16.2025 Research, science & health
Tiré de New Theory of Colours de Mary Gartside, 1808
Aphantasia Might Be Linked to Alterations in Brain Connectivity
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA's neuroimaging centre, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, publiés [i] in Cortex, pave the...
06.06.2025 Research, science & health
Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
See all our news